8-K

Exhibit 99.1


Corporate News Release		Celanese Corporation Investor Relations 1601 West LBJ Freeway Dallas, Texas 75234-6034

Celanese Corporation Reports Record Fourth Quarter and Full Year Results; Raises Outlook for 2008

Fourth quarter highlights:

	•		Net sales increased 23% to $1,760 million from prior year

	•		Operating profit more than doubled to $324 million

	•		Net earnings increased to $214 million from $77 million in prior year

	•		Operating EBITDA increased 30% to $349 million

	•		Diluted EPS increased to $1.27 from $0.45 in prior year

	•		Adjusted EPS increased to $0.93 from $0.61 in prior year

	•		2008 adjusted earnings per share outlook raised to between $3.40 and $3.70 from previous guidance of between $3.35 and $3.65

Full year highlights:

	•		Net sales increased 12% to $6,444 million from prior year

	•		Operating profit increased 21% to $748 million

	•		Adjusted EPS increased to $3.42 from $2.62

	•		Operating EBITDA increased 16% to $1,325 million



	Three Months Ended				Twelve Months Ended
	December 31,				December 31,
(in $ millions, except per share data)	2007		2006		2007		2006

Net sales		1,760		1,430		6,444		5,778
Operating profit		324		140		748		620
Net earnings		214		77		426		406
Operating EBITDA ¹		349		269		1,325		1,144
Diluted EPS — continuing operations	$	1.23	$	0.18	$	1.96	$	1.74
Diluted EPS — Total	$	1.27	$	0.45	$	2.49	$	2.36
Adjusted EPS ¹	$	0.93	$	0.61	$	3.42	$	2.62


¹		Non-U.S. GAAP measures. See reconciliation in tables 1 and 6.

Dallas, February 5, 2008: Celanese Corporation (NYSE: CE) today reported record net sales of $1,760 million, a 23 percent increase from the prior year. Higher pricing on continued strong global demand for Acetyl Intermediates products, positive currency impacts, growth in Asia supported by the company’s new acetic acid unit in Nanjing, China, and sales from the acquired Acetate Products Limited (APL) business drove the increase. Operating profit increased to $324 million from $140 million in the prior year period and included a total of $93 million of certain other adjustments. These adjustments include a $34 million gain on the sale of the company’s facility in Edmonton, Canada, a $31 million gain on resolution of commercial disputes with a vendor, and a $40 million net gain from a partial insurance recovery related to the outage at the company’s Clear Lake, Texas, facility. Excluding the adjustments, the increase in operating profit was driven primarily by expanded margins in Acetyl Intermediates and Industrial Specialties, as well as profitable growth from the Nanjing, China, facility. Net earnings were $214 million compared with $77 million in the prior year period.

Page 2 of 13

Adjusted earnings per share for the fourth quarter were $0.93 compared with $0.61 in the same period last year. The tax rate used for adjusted earnings per share was 28 percent and 25 percent for the fourth quarters of 2007 and 2006, respectively. Operating EBITDA was $349 million in the quarter versus $269 million in the prior year period. Fourth quarter 2007 adjusted earnings per share and operating EBITDA, which exclude the $93 million of other adjustments, reflect record performance for the company.

“Celanese’s integrated business model continued to deliver high quality earnings,” said David Weidman, chairman and chief executive officer. “Our global presence and continued execution of our focused growth strategy drove excellent results in the quarter.”

Full Year 2007 Results

Net sales for 2007 were $6,444 million, a 12 percent increase from 2006, primarily driven by overall higher pricing on continued strong demand, positive currency effects and additional sales from the APL business. Operating profit was $748 million compared with $620 million in the same period last year. Excluding the one-time adjustments in both periods, the underlying increase is driven by growth across all businesses and lower selling, general and administrative expenses related to the company’s operational excellence initiatives. Operating EBITDA for the full year 2007 was $1,325 million compared with $1,144 million in the same period last year. Adjusted earnings per share were $3.42 versus $2.62 in 2006.

Recent Highlights

	•		Reached a definitive agreement with Southwest Research and Design Institute of Chemical Industry, based in China, that will accelerate the company’s research and development efforts in acetyl products.

	•		Entered into a long-term supply agreement to secure availability of carbon monoxide (CO) to increase reliability of supply and support future expansion of acetic acid capacity at the company’s Nanjing, China, complex.

	•		Began commercial sales from the emulsions unit at the company’s fully integrated chemical complex in Nanjing.

	•		Consistent with its growth strategy in China for Advanced Engineered Materials, commissioned startup of its Celstran^® long fiber-reinforced thermoplastic (LFRT) unit in Nanjing, China. Also announced plans to add a polymer compounding unit to the Nanjing complex.

	•		Raised 2010 strategic growth objectives by $50 million to between $350 million and $400 million in additional operating EBITDA from its 2006 baseline.

	•		Upgraded by Standard & Poor’s with a positive outlook and corporate credit rating of ‘BB’ from ‘BB-.’ The global credit rating agency also raised the company’s senior secured bank loan rating from ‘BB’ to ‘BB+’ and affirmed its ‘2’ recovery rating.

Fourth Quarter Segment Overview

Advanced Engineered Materials

New product applications and strong demand in Europe and the Americas drove continued growth in Advanced Engineered Materials. The businesses, however, experienced ongoing margin pressure due to high raw material and energy costs. Net sales increased to $253 million from $224 million in the same period last year on higher

Page 3 of 13

volumes and positive currency impacts. Operating profit increased to $30 million from $29 million as the volume growth was offset by higher raw material and energy costs and overall lower pricing due to product and application mix. Operating profit includes approximately $10 million in other adjustments, primarily related to an insurance settlement in the period. Operating EBITDA, which excludes the adjustments, decreased to $45 million from $58 million in the prior year period, primarily driven by lower overall earnings from equity affiliates.

Consumer Specialties

Consumer Specialties realized benefits from its European growth initiative as sales and earnings significantly increased from the prior year. Net sales increased to $279 million from $224 million in the same period last year, primarily driven by $62 million of additional net sales from the APL business during the quarter. Higher pricing, driven by continued strong demand, also contributed to the increased sales. The increase was partially offset by lower volumes associated with the company’s strategy to shift flake production to its China ventures. Operating profit increased to $69 million from $41 million in the prior year period and included $27 million of non-recurring benefits, principally from the sale of the Edmonton, Canada, facility and the partial insurance recovery. Incremental operating profit from the APL acquisition, positive impacts from the Acetate Products revitalization, and overall higher pricing on continued strong demand offset higher raw material and energy costs in the period. Operating EBITDA increased to $57 million compared with $53 million in the same period last year. The Nutrinova business continued to deliver stable earnings in the period.

Industrial Specialties

With strong performance and leading global positions, Industrial Specialties delivered improved results in the quarter. Net sales increased to $331 million compared with $309 million in the prior year period. The increase, primarily driven by higher pricing on continued strong demand and positive currency impacts, was partially offset by lower volumes resulting from the residual impact of the company’s unplanned acetic acid outage at its Clear Lake, Texas, facility. Operating profit was $26 million, a $17 million increase from the prior year period, and operating EBITDA was $41 million compared with $25 million in 2006.

Acetyl Intermediates

Acetyl Intermediates’ growth in Asia and continued favorable dynamics drove record performance in the quarter. Net sales were $1,083 million compared with $831 million in the prior year period. The increase is attributed to higher pricing resulting from continued strong demand and industry production outages, increased volumes and positive currency impacts in the period. Increased volumes were primarily driven by production from the company’s new acetic acid unit in Nanjing, China. Operating profit was $276 million compared with $107 million in the same period last year, driven by the higher pricing and increased volumes. Results also included approximately $97 million of one-time gains primarily associated with a resolution of commercial disputes with a vendor, the partial insurance recovery and the sale of the company’s Edmonton, Canada, facility. Operating EBITDA, which excludes the one-time gains, increased to $231 million from $169 million in the same period last year, driven by the higher operating profit and higher dividend income from the company’s Ibn Sina cost affiliate.

Taxes

The tax rate for adjusted earnings per share was 28 percent in the fourth quarter of 2007 compared with 25 percent for the fourth quarter of 2006. The U.S. GAAP effective tax rate for continuing operations for 2007 was

Page 4 of 13

25 percent versus 42 percent in 2006. The U.S. GAAP rate for 2007 is lower primarily due to increased earnings in tax jurisdictions with reduced tax rates and the favorable impact from the recent German tax rate reduction. These benefits are partially offset by the accounting treatment for the recent tax law change in Mexico in the fourth quarter of 2007. Cash taxes for 2007 were $191 million compared with $101 million in 2006, primarily as a result of the timing of cash taxes in Germany. The new tax laws in Mexico are not expected to materially impact cash taxes in future periods.

Equity and Cost Investments

Earnings from equity investments and dividends from cost investments, which are reflected in the company’s adjusted earnings and operating EBITDA, totaled $40 million in the fourth quarter and were flat compared with 2006 results. Higher dividends received from the company’s Ibn Sina cost affiliate offset lower earnings in the Advanced Engineered Materials equity affiliates. Equity and cost investment dividends, which are included in operating cash flow, were $26 million compared with $73 million in the prior year period, primarily due to a special dividend from the company’s Polyplastics equity affiliate received in the fourth quarter of 2006.

Cash Flow

For the full year 2007, the company generated approximately $566 million in cash flow from operations compared with $751 million in 2006. Excluding adjustments to operating cash for discontinued operations in both periods, cash flow from operations was $650 million and $741 million for 2007 and 2006, respectively. Through the end of the fourth quarter 2007, the company paid $191 million in cash taxes, a $90 million increase from the same period in 2006.

“Our strong operational cash generation in 2007 provides a solid platform for future growth and delivering shareholder value,” said Steven Sterin, senior vice president and chief financial officer. “In 2008, we expect adjusted free cash flow of between $500 million and $550 million, driven by strong earnings and lower cash taxes.”

Cash and cash equivalents at the end of the fourth quarter were $825 million, a $34 million increase from the end of 2006 and a $294 million increase from the end of the third quarter of 2007. During the fourth quarter of 2007, the company received $31 million from resolution of commercial disputes with a vendor, cash proceeds of $33 million from the sale of the Edmonton, Canada, facility and a $33 million net insurance recovery progress payment related to the unplanned outage at its Clear Lake, Texas, facility. Net debt at the end of the fourth quarter was $2,731 million, a slight increase from $2,707 million at the end of 2006.

Outlook

Based on continued strength in its global markets and progress in executing its strategic growth plans, the company raised its full year 2008 outlook for adjusted earnings per share to between $3.40 and $3.70 from its previous guidance range of between $3.35 and $3.65. The company’s guidance is based on a tax rate of 26 percent and a year-end weighted average of 169 million diluted shares outstanding. The company also raised its guidance range for operating EBITDA to between $1,290 million and $1,360 million from its previous guidance range of between $1,280 million and $1,350 million.

Page 5 of 13

“With our resilient portfolio, geographic reach, and diversified end market exposure, Celanese is well positioned to mitigate the impacts of an uncertain economic environment and deliver sustained earnings growth. In 2008, we expect to build on our track record of execution and drive improved performance across our business,” Weidman said.


Contacts:
Investor Relations		Media
Mark Oberle		Jeremy Neuhart
Phone: +1 972 443 4464		Phone: +1 972 443 3750
Telefax: +1 972 332 9373		Telefax: +1 972 443 8519
Email: Mark.Oberle@celanese.com		Jeremy.Neuhart@celanese.com

As a global leader in the chemicals industry, Celanese Corporation makes products essential to everyday living. Our products, found in consumer and industrial applications, are manufactured in North America, Europe and Asia. Net sales totaled $6.4 billion in 2007, with approximately 70% generated outside of North America. Known for operational excellence and execution of its business strategies, Celanese delivers value to customers around the globe with innovations and best-in-class technologies. Based in Dallas, Texas, the company employs approximately 8,400 employees worldwide. For more information on Celanese Corporation, please visit the company’s website at www.celanese.com.

Forward-Looking Statements

This release may contain “forward-looking statements,” which include information concerning the company’s plans, objectives, goals, strategies, future revenues or performance, capital expenditures, financing needs and other information that is not historical information. When used in this release, the words “outlook,” “forecast,” “estimates,” “expects,” “anticipates,” “projects,” “plans,” “intends,” “believes,” and variations of such words or similar expressions are intended to identify forward-looking statements. All forward-looking statements are based upon current expectations and beliefs and various assumptions. There can be no assurance that the company will realize these expectations or that these beliefs will prove correct. There are a number of risks and uncertainties that could cause actual results to differ materially from the forward-looking statements contained in this release. Numerous factors, many of which are beyond the company’s control, could cause actual results to differ materially from those expressed as forward-looking statements. Certain of these risk factors are discussed in the company’s filings with the Securities and Exchange Commission. Any forward-looking statement speaks only as of the date on which it is made, and the company undertakes no obligation to update any forward-looking statements to reflect events or circumstances after the date on which it is made or to reflect the occurrence of anticipated or unanticipated events or circumstances.

Reconciliation of Non-U.S. GAAP Measures to U.S. GAAP

This release reflects five performance measures, operating EBITDA, affiliate EBITDA, adjusted earnings per share, net debt and adjusted free cash flow, as non-U.S. GAAP measures. The most directly comparable financial measure presented in accordance with U.S. GAAP in our consolidated financial statements for operating EBITDA is operating profit; for affiliate EBITDA is equity in net earnings of affiliates; for adjusted earnings per share is earnings per common share-diluted; for net debt is total debt; and for adjusted free cash flow is cash flow from operations.

Use of Non-U.S. GAAP Financial Information

	•		Operating EBITDA, a measure used by management to measure performance, is defined as operating profit from continuing operations, plus equity in net earnings from affiliates, other income and depreciation and amortization, and further adjusted for other charges and adjustments. We provide guidance on operating EBITDA and are unable to reconcile forecasted operating EBITDA to a GAAP financial measure because a forecast of Other Charges and Adjustments is not practical. Our management believes operating EBITDA is useful to investors because it is one of the primary measures our management uses for its planning and budgeting processes and to monitor and evaluate financial and operating results. Operating EBITDA is not a recognized term under U.S. GAAP and does not purport to be an alternative to operating profit as a measure of operating performance or to cash flows from operating activities as a measure of liquidity. Because not all companies use identical calculations, this presentation of operating EBITDA may not be comparable to other similarly titled measures of other companies. Additionally, operating EBITDA is not intended to be a measure of free cash flow for management’s discretionary use, as it does not consider certain cash requirements such as interest payments, tax payments and debt service requirements nor does it represent the amount used in our debt covenants.

	•		Affiliate EBITDA, a measure used by management to measure performance of its equity investments, is defined as the proportional operating profit plus the proportional depreciation and amortization of its equity investments. Affiliate EBITDA, including Celanese Proportional Share of affiliate information on Table 8, is not a recognized term under U.S. GAAP and is not meant to be an alternative to operating cash flow of the equity investments. The company has determined that it does not have sufficient ownership for operating control of these investments to consider their results on a consolidated basis. The company believes that investors should consider affiliate EBITDA when determining the equity investments’ overall value in the company.

Page 6 of 13

	•		Adjusted earnings per share is a measure used by management to measure performance. It is defined as net earnings (loss) available to common shareholders plus preferred dividends, adjusted for other charges and adjustments, and divided by the number of basic common shares, diluted preferred shares, and options valued using the treasury method. We provide guidance on an adjusted earnings per share basis and are unable to reconcile forecasted adjusted earnings per share to a GAAP financial measure because a forecast of Other Items is not practical. We believe that the presentation of this non-U.S. GAAP measure provides useful information to management and investors regarding various financial and business trends relating to our financial condition and results of operations, and that when U.S. GAAP information is viewed in conjunction with non-U.S. GAAP information, investors are provided with a more meaningful understanding of our ongoing operating performance. This non-U.S. GAAP information is not intended to be considered in isolation or as a substitute for U.S. GAAP financial information.

	•		Net debt is defined as total debt less cash and cash equivalents. We believe that the presentation of this non-U.S. GAAP measure provides useful information to management and investors regarding changes to the company’s capital structure. Our management and credit analysts use net debt to evaluate the company’s capital structure and assess credit quality. This non-U.S. GAAP information is not intended to be considered in isolation or as a substitute for U.S. GAAP financial information.

	•		Adjusted free cash flow is defined as cash flow from operations less capital expenditures, other productive asset purchases, operating cash from discontinued operations and certain other charges. We believe that the presentation of this non-U.S. GAAP measure provides useful information to management and investors regarding changes to the company’s cash flow. Our management and credit analysts use adjusted free cash flow to evaluate the company’s liquidity and assess credit quality. This non-U.S. GAAP information is not intended to be considered in isolation or as a substitute for U.S. GAAP financial information.

Results Unaudited

The results presented in this release, together with the adjustments made to present the results on a comparable basis, have not been audited and are based on internal financial data furnished to management. Quarterly results should not be taken as an indication of the results of operations to be reported for any subsequent period or for the full fiscal year.

Page 7 of 13

Preliminary Consolidated Statements of Operations — Unaudited


	Three Months Ended						Twelve Months Ended
	December 31,						December 31,
(in $ millions, except per share data)	2007			2006			2007			2006

Net sales		1,760			1,430			6,444			5,778
Cost of sales		(1,348	)		(1,119	)		(4,999	)		(4,469	)

Gross profit		412			311			1,445			1,309

Selling, general and administrative expenses		(145	)		(134	)		(516	)		(536	)
Amortization of Intangibles ¹		(19	)		(17	)		(72	)		(66	)
Research and development expenses		(19	)		(17	)		(73	)		(65	)
Other (charges) gains, net		60			2			(58	)		(10	)
Foreign exchange gain (loss), net		2			—			2			(3	)
Gain (loss) on disposition of assets, net		33			(5	)		20			(9	)

Operating profit		324			140			748			620

Equity in net earnings of affiliates		17			23			82			76
Interest expense		(66	)		(76	)		(262	)		(293	)
Refinancing expenses		—			—			(256	)		(1	)
Interest income		10			11			44			37
Dividend income — cost investments		23			17			116			79
Other income (expense), net		5			10			(25	)		8

Earnings from continuing operations before tax and minority interests		313			125			447			526

Income tax provision		(104	)		(94	)		(110	)		(222	)

Earnings from continuing operations before minority interests		209			31			337			304

Minority interests		(1	)		(1	)		(1	)		(4	)

Earnings from continuing operations		208			30			336			300

Earnings from discontinued operations:
Earnings from operation of discontinued operations		2			45			40			130
Gain on disposal of discontinued operations		5			1			52			5
Income tax benefit (provision)		(1	)		1			(2	)		(29	)

Earnings from discontinued operations		6			47			90			106

Net earnings		214			77			426			406


Cumulative preferred stock dividend		(3	)		(2	)		(10	)		(10	)

Net earnings available to common shareholders		211			75			416			396


Earnings per common share — basic:
Continuing operations	$	1.35		$	0.18		$	2.11		$	1.83
Discontinued operations		0.04			0.29			0.58			0.67

Net earnings available to common shareholders	$	1.39		$	0.47		$	2.69		$	2.50


Earnings per common share — diluted:
Continuing operations	$	1.23		$	0.18		$	1.96		$	1.74
Discontinued operations		0.04			0.27			0.53			0.62

Net earnings available to common shareholders	$	1.27		$	0.45		$	2.49		$	2.36


Weighted average shares — basic		151.7			158.7			154.5			158.6
Weighted average shares — diluted		168.6			172.5			171.2			171.8


¹		Customer related intangibles

Page 8 of 13

Preliminary Consolidated Balance Sheets — Unaudited


	December 31,			December 31,
(in $ millions)	2007			2006

ASSETS
Current assets:
Cash and cash equivalents		825			791
Restricted cash		—			46
Receivables:
Trade receivables — third party and affiliates, net		1,009			1,001
Other receivables		437			475
Inventories		636			653
Deferred income taxes		60			76
Other assets		86			69

Total current assets		3,053			3,111

Investments		814			763
Property, plant and equipment, net		2,362			2,155
Deferred income taxes		58			22
Other assets		518			506
Goodwill		866			875
Intangible assets, net		425			463

Total assets		8,096			7,895


LIABILITIES AND SHAREHOLDERS’ EQUITY
Current liabilities:
Short-term borrowings and current installments of long-term debt — third party and affiliates		272			309
Trade payables — third parties and affiliates		818			830
Other current liabilities		888			780
Deferred income taxes		20			18
Income taxes payable		23			279

Total current liabilities		2,021			2,216

Long-term debt		3,284			3,189
Deferred income taxes		308			297
Income taxes payable		220			—
Benefit obligations		696			889
Other liabilities		495			443
Minority interests		5			74
Shareholders’ equity:
Preferred stock		—			—
Common stock		—			—
Treasury stock, at cost		(403	)		—
Additional paid-in capital		469			362
Retained earnings		799			394
Accumulated other comprehensive income (loss), net		202			31

Total shareholders’ equity		1,067			787

Total liabilities and shareholders’ equity		8,096			7,895

Page 9 of 13

Table 1

Segment Data and Reconciliation of Operating Profit (Loss) to Operating EBITDA — a Non-U.S. GAAP Measure


	Three Months Ended						Twelve Months Ended
	December 31,						December 31,
(in $ millions)	2007			2006			2007			2006

Net Sales
Advanced Engineered Materials		253			224			1,030			915
Consumer Specialties		279			224			1,111			876
Industrial Specialties		331			309			1,346			1,281
Acetyl Intermediates		1,083			831			3,615			3,351
Other Activities ¹		—			6			2			22
Intersegment eliminations		(186	)		(164	)		(660	)		(667	)

Total		1,760			1,430			6,444			5,778


Operating Profit (Loss)
Advanced Engineered Materials		30			29			133			145
Consumer Specialties		69			41			199			165
Industrial Specialties		26			9			28			44
Acetyl Intermediates		276			107			616			456
Other Activities ¹		(77	)		(46	)		(228	)		(190	)

Total		324			140			748			620


Equity Earnings and Other Income/(Expense) ²
Advanced Engineered Materials		7			13			55			55
Consumer Specialties		3			2			40			24
Industrial Specialties		—			—			—			(1	)
Acetyl Intermediates		27			23			78			63
Other Activities ¹		8			12			—			22

Total		45			50			173			163


Other Charges and Other Adjustments ³
Advanced Engineered Materials		(10	)		(1	)		(5	)		(5	)
Consumer Specialties		(27	)		—			(16	)		—
Industrial Specialties		(1	)		2			32			16
Acetyl Intermediates		(97	)		16			(38	)		52
Other Activities ¹		42			(2	)		140			29

Total		(93	)		15			113			92


Depreciation and Amortization Expense
Advanced Engineered Materials		18			17			69			65
Consumer Specialties		12			10			51			39
Industrial Specialties		16			14			59			59
Acetyl Intermediates		25			23			106			101
Other Activities ¹		2			—			6			5

Total		73			64			291			269


Operating EBITDA
Advanced Engineered Materials		45			58			252			260
Consumer Specialties		57			53			274			228
Industrial Specialties		41			25			119			118
Acetyl Intermediates		231			169			762			672
Other Activities ¹		(25	)		(36	)		(82	)		(134	)

Total		349			269			1,325			1,144


¹		Other Activities primarily includes corporate selling, general and administrative expenses and the results from captive insurance companies. The 2007 Operating Profit (Loss) and Other Charges and Other Adjustments amounts include deductible associated with insurance recovery

²		Includes equity earnings from affiliates, dividends from cost investments and other income/(expense).

³		Excludes adjustments to minority interest, net interest, taxes, depreciation, amortization and discontinued operations (See Table 7).

Page 10 of 13

Table 2

Factors Affecting Fourth Quarter 2007 Segment Net Sales Compared to Fourth Quarter 2006


(in percent)	Volume			Price			Currency			Other ¹			Total

Advanced Engineered Materials		8	%		-1	%		6	%		0	%		13	%
Consumer Specialties		-7	%		3	%		1	%		28	%		25	%
Industrial Specialties		-3	%		5	%		6	%		-1	%		7	%
Acetyl Intermediates		12	%		13	%		5	%		0	%		30	%
Total Company		6	%		9	%		6	%		2	%		23	%

Factors Affecting Twelve Months 2007 Segment Net Sales Compared to Twelve Months 2006


(in percent)	Volume			Price			Currency			Other ¹			Total

Advanced Engineered Materials		9	%		-1	%		5	%		0	%		13	%
Consumer Specialties		-4	%		4	%		1	%		26	%		27	%
Industrial Specialties		-1	%		2	%		5	%		-1	%		5	%
Acetyl Intermediates		-5	%		9	%		4	%		0	%		8	%
Total Company		-2	%		6	%		4	%		4	%		12	%


¹		Primarily represents net sales from APL (Acetate), divestiture of AT Plastics Films business and captive insurance companies (Total Company).

Table 3

Cash Flow Information


	Twelve Months Ended
	December 31,
(in $ millions)	2007			2006

Net cash provided by operating activities		566			751
Net cash provided by (used in) investing activities		143			(268	)
Net cash used in financing activities		(714	)		(108	)
Exchange rate effects on cash		39			26
Cash and cash equivalents at beginning of period		791			390

Cash and cash equivalents at end of period		825			791

Table 4

Cash Dividends Received

Three Months Ended

Twelve Months Ended

December 31,

(in $ millions)

2007

2006

2007

2006

Dividends from equity investments

109

Dividends from cost investments

116

Total

173

188

Table 5

Net Debt — Reconciliation of a Non-U.S. GAAP Measure


	December 31,		December 31,
(in $ millions)	2007		2006

Short-term borrowings and current installments of long-term debt — third party and affiliates		272		309
Long-term debt		3,284		3,189

Total debt		3,556		3,498
Less: Cash and cash equivalents		825		791

Net Debt		2,731		2,707

Page 11 of 13

Table 6

Adjusted Earnings Per Share — Reconciliation of a Non-U.S. GAAP Measure


	Three Months Ended						Twelve Months Ended
	December 31,						December 31,
(in $ millions, except per share data)	2007			2006			2007			2006

Earnings from continuing operations before tax and minority interests		313			125			447			526
Non-GAAP Adjustments:
Other charges and other adjustments ¹		(93	)		15			113			92
Refinancing costs		—			—			254			—

Adjusted earnings from continuing operations before tax and minority interests		220			140			814			618
Income tax provision on adjusted earnings ²		(62	)		(35	)		(228	)		(163	)
Minority interests		(1	)		(1	)		(1	)		(4	)

Adjusted earnings from continuing operations		157			104			585			451
Preferred dividends		(3	)		(2	)		(10	)		(10	)

Adjusted net earnings available to common shareholders		154			102			575			441
Add back: Preferred dividends		3			2			10			10

Adjusted net earnings for adjusted EPS		157			104			585			451

Diluted shares (millions)

Weighted average shares outstanding

151.7

158.7

154.5

158.6

Assumed conversion of Preferred Shares

12.0

12.0

12.0

12.0

Assumed conversion of Restricted Stock

0.6

—

0.4

—

Assumed conversion of stock options

4.3

1.8

4.3

1.2

Total diluted shares

168.6

172.5

171.2

171.8

Adjusted EPS

0.93

0.61

3.42

2.62


¹		See Table 7 for details

²		The adjusted tax rate for the three and twelve months ended December 31, 2007 is 28% based on the original full year 2007 guidance.

Page 12 of 13

Table 7

Reconciliation of Other Charges and Other Adjustments

Other Charges:


	Three Months Ended						Twelve Months Ended
	December 31,						December 31,
(in $ millions)	2007			2006			2007			2006

Employee termination benefits		5			1			32			12
Plant/office closures		7			(1	)		11			(1	)
Insurance recoveries associated with plumbing cases		(2	)		(2	)		(4	)		(5	)
Insurance recoveries associated with Clear Lake, Texas		(40	)		—			(40	)		—
Resolution of commercial disputes with a vendor		(31	)		—			(31	)		—
Deferred compensation triggered by Exit Event		—			—			74			—
Asset impairments		—			—			9			—
Ticona Kelsterbach plant relocation		1			—			5			—
Other		—			—			2			4

Total		(60	)		(2	)		58			10

Other Adjustments: ¹


	Three Months Ended						Twelve Months Ended
	December 31,						December 31,
(in $ millions)	2007			2006			2007			2006

Executive severance & other costs related to Squeeze-Out		—			2			—			30
Ethylene pipeline exit costs		—			—			10			—
Business optimization		8			8			18			12
Foreign exchange loss related to refinancing transaction		—			—			22			—
Loss on AT Plastics films sale		—			—			7			—
Discontinued methanol production ²		—			16			31			52
Gain on disposal of investment (Pemeas)		—			(11	)		—			(11	)
Gain on Edmonton sale		(34	)		—			(34	)		—
Other		(7	)		2			1			(1	)

Total		(33	)		17			55			82


Total other charges and other adjustments		(93	)		15			113			92


¹		These items are included in net earnings but not included in other charges.

²		Adjusted earnings per share included earnings from its discontinued methanol production which was included in the company’s 2007 guidance.

Page 13 of 13

Table 8

Equity Affiliate Preliminary Results — Total — Unaudited


	Three Months Ended				Twelve Months Ended
(in $ millions)	December 31,				December 31,
	2007		2006		2007		2006

Net Sales
Ticona Affiliates¹		336		310		1,270		1,172
Infraserv²		623		381		1,798		1,391

Total		959		691		3,068		2,563


Operating Profit
Ticona Affiliates		40		41		188		171
Infraserv		26		13		87		60

Total		66		54		275		231


Depreciation and Amortization
Ticona Affiliates		17		16		56		51
Infraserv		26		22		87		81

Total		43		38		143		132


Affiliate EBITDA³
Ticona Affiliates		57		57		244		222
Infraserv		52		35		174		141

Total		109		92		418		363


Net Income
Ticona Affiliates		21		27		119		112
Infraserv		20		15		79		53

Total		41		42		198		165


Net Debt
Ticona Affiliates		208		25		208		25
Infraserv		39		25		39		25

Total		247		50		247		50

Equity Affiliate Preliminary Results — Celanese Proportional Share — Unaudited⁴


	Three Months Ended				Twelve Months Ended
(in $ millions)	December 31,				December 31,
	2007		2006		2007		2006

Net Sales
Ticona Affiliates		155		143		587		542
Infraserv		199		124		587		518

Total		354		267		1,174		1,060


Operating Profit
Ticona Affiliates		19		19		89		81
Infraserv		9		5		29		21

Total		28		24		118		102


Depreciation and Amortization
Ticona Affiliates		8		7		26		24
Infraserv		11		6		31		25

Total		19		13		57		49


Affiliate EBITDA³
Ticona Affiliates		27		26		115		104
Infraserv		20		11		59		45

Total		47		37		174		149


Equity in net earnings of affiliates (as reported on the Income Statement)
Ticona Affiliates		9		13		56		52
Infraserv		7		7		25		21
Other⁵		1		3		1		3

Total		17		23		82		76


Affiliate EBITDA in excess of Equity in net earnings of affiliates⁶
Ticona Affiliates		18		13		59		52
Infraserv		13		4		34		24

Total		31		17		93		76


Net Debt
Ticona Affiliates		96		11		96		11
Infraserv		15		11		15		11

Total		111		22		111		22


¹		Ticona Affiliates includes PolyPlastics (45% ownership), Korean Engineering Plastics (50%) and Fortron Industries(50%)

²		Infraserv includes Infraserv Entities valued as equity investments (Infraserv Höchst Group — 31% ownership, Infraserv Gendorf — 39% and Infraserv Knapsack 27%)

³		Affiliate EBITDA is the sum of Operating Profit and Depreciation and Amortization, a non-U.S. GAAP measure

⁴		Calculated as the product of figures from the above table times Celanese ownership percentage

⁵		This represents liquidating dividends from Clear Lake Methanol Patrners^.

⁶		Product of Celanese proportion of Affiliate EBITDA less Equity in net earnings of affiliates; not included in Celanese operating EBITDA


DELAWARE	001-32410	98-0420726

(State or other jurisdiction of incorporation)	(Commission File Number)	(IRS Employer Identification No.)


Exhibit Number		Description

99.1		Press Release dated February 5, 2008*

99.2		Slide Presentation dated February 5, 2008*


CELANESE CORPORATION
By:	/s/ Miguel A. Desdin
	Name:	Miguel A. Desdin
	Title:	Vice President and Controller


Exhibit Number		Description

99.1		Press Release dated February 5, 2008*

99.2		Slide Presentation dated February 5, 2008*


o		Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)


o		Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)


o		Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))


Item 2.02		Results of Operations and Financial Condition


*		In connection with the disclosure set forth in Item 2.02 and Item 7.01, the information in this Current Report, including the exhibits attached hereto, is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of such section. The information in this Current Report, including the exhibits, shall not be incorporated by reference into any filing under the Securities Act of 1933, as amended or the Exchange Act, regardless of any incorporation by reference language in any such filing. This Current Report will not be deemed an admission as to the materiality of any information in this Current Report that is required to be disclosed solely by Regulation FD.


Item 7.01		Regulation FD Disclosure


Item 9.01		Financial Statements and Exhibits.